A detailed history of Chilton Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Chilton Capital Management LLC holds 15,639 shares of LLY stock, worth $13.9 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
15,639
Previous 15,661 0.14%
Holding current value
$13.9 Million
Previous $12.2 Million 16.22%
% of portfolio
0.65%
Previous 0.59%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

SELL
$724.87 - $909.04 $15,947 - $19,998
-22 Reduced 0.14%
15,639 $14.2 Million
Q1 2024

May 07, 2024

BUY
$592.2 - $792.28 $17,173 - $22,976
29 Added 0.19%
15,661 $12.2 Million
Q4 2023

Jan 18, 2024

SELL
$525.19 - $619.13 $525 - $619
-1 Reduced 0.01%
15,632 $9.11 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $434 - $599
1 Added 0.01%
15,633 $8.4 Million
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $2.82 Million - $3.65 Million
15,632 New
15,632 $3.59 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $847B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Chilton Capital Management LLC Portfolio

Follow Chilton Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chilton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chilton Capital Management LLC with notifications on news.